Target intelligence / Profile preview

Ribosomal protein L17 pseudogene 36 (RPL17P36)

Target: RPL17P36
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L17 pseudogene 36 (RPL17P36) is a processed pseudogene in the human genome and does not encode a functional protein. It originated from the ribosomal protein L17 gene (RPL17), which encodes a structural component of the 60S ribosomal subunit, but RPL17P36 itself is a non-functional copy, lacking the ability to produce a ribosomal protein or participate directly in ribosomal assembly or protein synthesis[13][4][11]. There is no established biological function, disease association, or druggability for this pseudogene.

Other names: RPL17_11_1102RPL17P36

Beyond the preview

Go deeper on Ribosomal protein L17 pseudogene 36 (RPL17P36).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L17 pseudogene 36 (RPL17P36).

Explore the full profile